Cedimed Life Science Private Limited

Cedimed Life Science Private Limited

Pharmaceutical company dealing with drugs, cosmetics, and distribution.
2019 | Thrissur, Kerala (India) | Active

Last Updated:

December 14, 2024
HomeCompanyCedimed Life Science Private Limited

Who are the key members and board of directors at Cedimed Life Science?

Executive Team (1)

NameDesignationAppointment DateStatus
Mohammed Haneefa InManaging Director02-Apr-2019Current

Board Members(3)

NameDesignationAppointment DateStatus
Karumankuzhiyil Asharaf In Director 02-Apr-2019Current
Thoombath Thahseen In Director 01-Jun-2019Current
Kallazhy Shoukathali In Director 02-Apr-2019Current

Financial Performance of Cedimed Life Science.

Enhance accessibility to Cedimed Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹1.00 M

LenderAmountStatus

Dhanlaxmi Bank Limited

Creation Date: 17 Nov 2021
₹1.00 MOpen

How Many Employees Work at Cedimed Life Science?

Unlock and access historical data on people associated with Cedimed Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Cedimed Life Science

Recent activity within the organization

  • Annual General Meeting

    Cedimed Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Cedimed Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.

    31 Mar 2024

  • Charges

    A charge with Dhanlaxmi Bank Limited amounted to Rs. 1.00 M with Charge ID 100508415 was registered on 17 Nov 2021.

    17 Nov 2021

  • Director Appointment

    Thoombath Edappanat Fathima Thahseen was appointed as a Director was appointed as a Director on 01 Jun 2019 & has been associated with this company since 5 years 6 months .

    01 Jun 2019

  • Director Appointment

    Karumankuzhiyil Asharaf was appointed as a Director was appointed as a Director on 02 Apr 2019 & has been associated with this company since 5 years 8 months .

    02 Apr 2019

  • Director Appointment

    Mohammed Chomayil Haneefa was appointed as a Managing Director was appointed as a Managing Director on 02 Apr 2019 & has been associated with this company since 5 years 8 months .

    02 Apr 2019

Frequently asked questions

  • Cedimed Life Science Private Limited was incorporated on 02 Apr 2019.

  • The authorized share capital of Cedimed Life Science Private Limited is ₹ 5.00 M and paid-up capital is ₹ 3.70 M.

  • Currently 4 directors are associated with Cedimed Life Science Private Limited.

    • Karumankuzhiyil Asharaf
    • Mohammed Chomayil Haneefa
    • Thoombath Edappanat Fathima Thahseen
    • Kallazhy Kunnath Kadher Shoukathali
  • As per Ministry of Corporate Affairs (Mca), the registered address of Cedimed Life Science Private Limited is Cedimed Life Science Private Limited Door No.3/254, Panamana Road India, Cheruthuruthy, Kerala, 679531.

  • The corporate identification number (CIN) of Cedimed Life Science Private Limited is U85100KL2019PTC057471 and the company number is 057471 as per Ministry of Corporate Affairs (MCA).

  • As per the financial statements for fiscal Year 0, The total open charges for Cedimed Life Science Private Limited amount to ₹ 1.00 M.

  • The most recent Balance Sheet for Cedimed Life Science Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development